Internal Medicine, Medical Oncology · The Villages, FL
NPI
1073742359
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2955 Brownwood Blvd Ste 107
The Villages, FL, 32163
Phone (352) 765-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
349,517 services
Medicare patients, 2024
1,470
Average age 77
Drug cost, 2024
$7.4M
1,881 prescriptions
Company payments, 2025
$3,350
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adewale A Fawole was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 45,900 times for 48 patients. In total Adewale A Fawole billed 349,517 services in 172 codes, and Medicare paid $4.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 45,900 | 48 | $0.28 | $13K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 39,660 | 34 | $0.22 | $8,574 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 17,300 | 13 | $0.06 | $955 |
| J0185 Injection, aprepitant, 1 mg | Office | 12,350 | 31 | $1.36 | $17K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 9,500 | 77 | $15.68 | $149K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,200 | 16 | $44.59 | $410K |
| J1434 Injection, fosaprepitant (focinvez), 1 mg | Office | 9,000 | 21 | $2.21 | $20K |
| J0897 Injection, denosumab, 1 mg | Office | 8,220 | 84 | $20.52 | $169K |
| J1756 Injection, iron sucrose, 1 mg | Office | 7,200 | 21 | $0.17 | $1,255 |
| Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | Office | 6,426 | 13 | $50.06 | $322K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,351 | 11 | $0.08 | $501 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 4,120 | 35 | $6.20 | $26K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,109 | 78 | $0.09 | $278 |
| 85025 Blood Count | Office | 2,616 | 1,005 | $7.61 | $20K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,538 | 11 | $35.52 | $90K |
By year: 2022 $4.4M for 361,074 services; 2023 $5.4M for 339,329 services; 2024 $4.4M for 349,517 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,616 | 1,005 | $7.61 | $20K |
| 36415 Venipuncture Blood Collection | 2,463 | 1,036 | $8.65 | $21K |
| 81003 Clinical Chemistry | 100 | 27 | $2.20 | $220 |
| 85610 Clinical Chemistry | 35 | 11 | $4.20 | $147 |
| 85045 Blood Count | 30 | 29 | $3.91 | $117 |
| 85046 Blood Count | 25 | 24 | $5.46 | $137 |
Medicare prescription drug claims, 2024
In 2024, the drug Adewale A Fawole prescribed most often to Medicare patients was Anastrozole, with 188 prescriptions and refills. In total Adewale A Fawole wrote 1,881 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 188 | 527 | 69 | $3,864 |
| Revlimid Lenalidomide | 145 | 145 | 16 | $2.2M |
| Eliquis Apixaban | 86 | 144 | 23 | $81K |
| Ondansetron Odt Ondansetron | 85 | 87 | 71 | $4,125 |
| Hydroxyurea Generic | 73 | 169 | 24 | $2,240 |
| Oxycodone Hcl Generic | 70 | 70 | 40 | $1,242 |
| Venclexta Venetoclax | 67 | 67 | 13 | $607K |
| Dexamethasone Generic | 52 | 68 | 40 | $1,213 |
| Abiraterone Acetate Generic | 47 | 47 | Under 11 | $45K |
| Brukinsa Zanubrutinib | 47 | 47 | Under 11 | $498K |
| Tamoxifen Citrate Generic | 47 | 126 | 19 | $2,488 |
| Prochlorperazine Maleate Generic | 45 | 45 | 33 | $638 |
| Prednisone Generic | 43 | 83 | 23 | $268 |
| Letrozole Generic | 43 | 116 | 14 | $1,707 |
| Zolpidem Tartrate Generic | 37 | 70 | 21 | $349 |
Brand drugs: - claims; generic drugs: 1,243 claims; opioid claims: 129.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adewale A Fawole $3,350 ($3,350 in general payments such as food, travel and fees) from 44 companies. The largest payer was Novartis Pharmaceuticals Corporation with $406.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 27 | $406 |
| Janssen Biotech, Inc. JNJ | 13 | $300 |
| Pfizer Inc. PFE | 10 | $193 |
| GlaxoSmithKline, LLC. GSK | 8 | $165 |
| Abbvie Inc. ABBV | 6 | $142 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $136 |
| BeOne Medicines USA, Inc. ONC | 6 | $133 |
| Daiichi Sankyo Inc. 4568.T | 6 | $132 |
| Celgene Corporation BMY | 5 | $125 |
| Gilead Sciences, Inc. GILD | 5 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.